Biotechnology & Medical Research

Page 1

United Therapeutics corporation announces executive promotions and CEO compensation change

Wednesday, 17 Dec 2014 06:00am EST

United Therapeutics Corp:Says promotion of Roger Jeffs, Ph.D. to President and Co-Chief Executive Officer and David Zaccardelli, Pharm.D. to Executive Vice President and Chief Operating Officer.In connection with these promotions, Dr. Rothblatt's title will change from Chairman and Chief Executive Officer to Chairman and Co-Chief Executive Officer.As Chairman of the Board and Co-Chief Executive Officer, Dr. Rothblatt will continue to serve as the principal executive officer of the company.These title changes will become effective Jan. 1, 2015.

Vermillion Inc names Valerie Palmieri as president and chief executive officer

Tuesday, 16 Dec 2014 11:05am EST

Vermillion Inc:Says next step in expanded strategy to rebuild company into premier bio-analytics solutions provider with naming of current chief operating officer, Valerie Palmieri to president and chief executive officer.While current chairman of board and CEO James LaFrance will continue to serve as chairman.These changes are effective Jan. 1, 2015.

Lion Biotechnologies announces appointment of President and Chief Executive Officer

Monday, 15 Dec 2014 08:01am EST

Lion Biotechnologies Inc:Appoints Elma Hawkins to serve as President and Chief Executive Officer, effective Jan. 1, 2015.

Actinogen Ltd announces appointment of Bill Ketelbey as CEO

Sunday, 14 Dec 2014 05:30pm EST

Actinogen Ltd:Says that Bill Ketelbey has been appointed as Chief Executive Officer.

Ovascience names new president - Form 8-K

Thursday, 11 Dec 2014 05:10pm EST

Ovascience Inc:Appointed Arthur Tzianabos as president.

AdvanSource Biomaterials announces resignation of CFO - Form 8-K

Thursday, 11 Dec 2014 04:25pm EST

AdvanSource Biomaterials Corporation:David Volpe resigned as chief financial officer on Dec. 8.

GI Dynamics Inc announces departure of Chief Financial Officer

Monday, 8 Dec 2014 07:00pm EST

GI Dynamics Inc:Says that the company and Robert W. Crane, its chief financial officer secretary and treasurer, have mutually agreed to Crane’s separation effective immediately.Says the separation is part of a broader restructuring and focusing of the company.

Synta Pharmaceuticals Corp appoints new CFO

Thursday, 4 Dec 2014 04:30pm EST

Synta Pharmaceuticals Corp:Appoints Chen Schor as company's Executive Vice President and Chief Operating Officer and Marc Schneebaum as company's Senior Vice President and Chief Financial Officer, both effective as of Dec. 08.Schneebaum will be replacing Keith S. Ehrlich, who will be stepping down as company's Chief Financial Officer, effective as of Dec. 08.Ehrlich will remain with company during a transition period.

Paratek Pharmaceuticals names new chief financial officer - Form 8-K

Wednesday, 3 Dec 2014 05:11pm EST

Paratek Pharmaceuticals, Inc:Announced appointment of Douglas W. Pagán as chief financial officer effective Dec. 18.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Thomson Reuters StreetEvents
$75.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.